He Xiaoshun, doctor of medicine, second-level professor, doctoral supervisor, central health care expert. 65438-0988 began to engage in organ transplantation and hepatobiliary surgery, specializing in liver transplantation to treat various liver cirrhosis, liver cancer and severe hepatitis; Combined pancreas-kidney transplantation, small intestine transplantation and multiple organ transplantation. Liver transplantation 1300 cases; He presided over the first successful abdominal multi-organ transplantation in Asia and was named as one of the "Top Ten News of China Medical Science and Technology" in that year; The first liver transplantation combined with pancreaticoduodenectomy in China for the treatment of hepatobiliary malignant tumor. The first single-segment liver transplantation in China was carried out; The first split liver transplantation in South China, double donor liver transplantation, ultra-right liver transplantation in middle hepatic vein, the first donor liver transplantation in China, and the first "two livers and three recipients" liver transplantation in Asia; The youngest infant liver transplant in China (three and a half months) and the oldest liver transplant in Asia (75 years old); Presided over the first mother-child small intestine transplantation operation in China; A series of international advanced transplantation operations, such as simultaneous pancreas-kidney transplantation, simultaneous liver-kidney transplantation and combined heart-liver transplantation. The organ transplant center led by him is one of the most diverse, largest and most effective transplant centers in China. It has also become the executive unit of China Liver Transplantation Training Center of the Department of International Cooperation of the Ministry of Health, the Organ Donation Research Center of Sun Yat-sen University, and the international cooperation project of organ donation of Hong Kong Rotary clubs. He has presided over many international academic conferences and introduced organ transplantation in China on behalf of the transplant community in China at WHO.